● Recruiting

Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

Condition: MRI-guided Adaptive Radiotherapy · Non-small Cell Lung Cancer · Brain Metastasis · Sponsor: Sun Yat-sen University

PhasePhase 2

Planned participants168

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study aims to explore the safety and efficacy of eliminating the planning target volume (PTV) margins based on MRI-guided adaptive stereotactic radiotherapy for non-small cell lung cancer (NSCLC) patients with brain metastasis.

This description comes directly from the study's public registry record.

Talk to the study team

Hui Liu · 13661150862 · liuhuisysucc@126.com

DaQuan Wang · 13661150862 · wangdq@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Sun yat-sen University Cancer Center

Guangzhou, Guangdong, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06582940